Related Experiment Video
Updated: Nov 15, 2025
06:02
Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
Published on: July 26, 2011
37.1K
Early Detection of Incipient Alzheimer Pathology: Time Is of the Essence
Frederik Barkhof1, Peter S Pressman2
1From the UCL Institutes of Neurology and Healthcare Engineering (F.B.), London, UK; Department of Radiology & Nuclear Medicine (F.B.), Amsterdam University Medical Centers, the Netherlands; and Department of Neurology (P.S.P.), Behavioral Neurology Section, University of Colorado Anschutz Medical Center, Aurora. f.barkhof@vumc.nl.
Neurology
|March 3, 2021
Abstract
No abstract available in PubMed .
Related Concept Videos
01:26Alzheimer's Disease: Overview
1.1K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.1K
01:22Alzheimer's Disease: Treatment
565
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
565